glp-1 gip Potential Use of and GIP/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at? Targeting GLP-1, GIP & GCG
Description
The GLP-1 component also counteracts the weight gain that insulin causes, creating a more balanced metabolic profile
Due to the complexity of its pathophysiology, a number of different therapeutic options are available for its treatment
Sodium-glucose co-transport inhibitors: progress and therapeutic potential in type 2 diabetes mellitus
Bethel MA, Diaz R, Castellana N, et al
Victoza (liraglutide): This type 2 diabetes medication is given as a subcutaneous injection (under the skin) once daily
